1

Curriculum Vitae

Dr. Farukh Arjmand Designation Professor

Address Department of Chemistry

Aligarh Muslim University

Aligarh–202002, India

Phone 0571–270921-3363

E–mail farukh_arjmand@yahoo.co.in

Date of Birth 10th Nov.1964

Academic Record

1986 Bachelors degree, University of Kashmir (J&K), India

1989 Masters in Chemistry, Aligarh Muslim University, (A.M.U.)

Aligarh, India

1990 M.Phil, A.M.U., Aligarh, India

1993 Ph.D. in Chemistry, A.M.U., Aligarh, India

Title of M.Phil and Ph.D: “Synthesis, Characterization and

Biocidal activity of Heterobimetallic Chelates”

1994–1998 Lecturer, Department of Chemistry, A.M.U., Aligarh

1998–2003 Senior Lecturer

2003–2006 Reader

2006–2009 Associate Professor

2009‒till date Professor

Teaching Experience 24 years

Research Experience 28 years

Awards/Recognition

2018– Certificate of recognition for “Important contribution in Chemistry’ by

Indo-US A.P.J. Abdul Kalam STEM ER Centre of OSU-AMU.

2016– ISCB Distinguished women scientist award

2010– Shiksha Rattan Puraskar IFSI, New Delhi

2005– Young Scientist ICC, Mumbai

2

Research Publications 124

Total Citations 2766

h-index 28

i10- index 74

Conferences and Symposia 46

Research Guidance

Ph.D 14+ 4* (See Annexure–1)

M.Phil 4 (*M. Phil.)

M.Sc. Projects 2+2*

Membership in Professional bodies

Chemical Research Society of India (CRSI) (Life member)

Indian Council of Chemists (ICC) (Life member)

Indian Society of Chemists and Biologists (ISCB) (Life member)

DNA Society of India, Kolkata (Life member)

American Chemical Society (Annual member‒2014, 2016‒2017)

Country visited for Academic pursuit

2018 Ras Sudr, South Sinai, Egypt, 13‒15th February 2018, 1st International

Conference on Nanotechnology and Biomaterials.

2013 Mansoura University, Sharm–El–Sheikh, Egypt, 11–15th Mar 2013

2008 Salve Regina University in New Port, RI United States,

Gordon Research Conference on Inorganic Chemistry, 13 –18th July, 2008.

2007 School of Life Science, University of Science and Technology, China,

Hefei (China). Visiting Scientist 1st June 2007 – 30th June 2007.

2002 School of Life Science, University of Science and Technology, China,

Hefei (China). Visiting Scientist August 2002 – September 2002.

Participation in Administration

2017-till date Co-Director, Indo-US Abdul Kalam Centre for STEM Education

and Research, joint collaborative project of AMU with Ohio State

University, USA

3

2018 Local Expert from India in ‘Women in STEM Roadshow’ organized by

US department of State, USA.

2015-2016 Provost , Indira Gandhi Hall, Aligarh Muslim University.

2015-2016 Member of A.M.U. Court, Aligarh Muslim University.

Research Areas

Design and synthesis of chiral metal–based antitumor chemotherapeutic drug

entities.

Synthesis of chiral amino acid N-N/ N-O ligand conjugates; peptides and

metallopeptides

Interaction of metal based drug entities with biological target molecules viz; DNA/

RNA/topoisomerases/nucleotides/ proteins

Structure elucidation by spectroscopic {IR, farIR, UV-vis, EPR, NMR, ESI-MS}

and biophysical techniques {UV-vis, fluorescence, CD, CV, Viscometric

measurements, in silico studies}

Invited Lectures

1. Lecture delivered at 1st International Conference on Nanotechnology and

Biomaterials: New Trends in Bone Tissue Engineering held at Ras Sudr, South

Sinai, Egypt, 13‒15th February 2018

2. Invited Lecture delivered at 23st International Conference of Indian Society of

Chemists and Biologists (ISCB) held at SRM University Chennai,

8th ‒10th February, 2017

3. Invited Lecture delivered at 21st International Conference of Indian Society of

Chemists and Biologists (ISCB) held at Central Drug Research Institute,

Lucknow, 25th‒28th February, 2015

4. Invited lecture delivered at Jamia Millia Islamia ,Refresher Course in Chemistry,

JMI–New Delhi, on ‘Supramolecular Chemistry’13th Oct 2014.

5. Lecture delivered at 11th International Conference on Chemistry and its Role in

Development held at Mansoura, Sharm–El–Sheikh, Egypt, 11–15th Mar (2013)

6. Lecture delivered at 15th International Conference of Indian Society of Chemists

and Biologists (ISCB) held at Saurashtra University, Rajkot, Gujarat, 4th–7th Feb

(2011)

7. Lecture delivered at 9th National symposium of Chemical Research Society of

India (CRSI) held at University of Delhi, Delhi, 1st– 4th Feb (2007)

8. Lecture delivered at 25th Conference of the Indian Council of Chemists held at

Birla College, Kalyan, Mumbai, 27– 29th December (2006)

Panel Discussion

4

Panelist for ICC Bangkok conference on Global challenges: a solution through chemistry

11–15th June 2011.

Projects Completed: 06

1. Third World Academy of Sciences (TWAS) Italy (1995–96)

2. Council of Scientific & Industrial Research, (CSIR) New Delhi, India (2001–

04)

3. University Grants Commission, New Delhi, India (2003–June 06)

4. Council of Scientific & Industrial Research, (CSIR) New Delhi, India (2005–

08)

5. Department of Biotechnology, New Delhi, India (2007–2009).

6. Department of Biotechnology, New Delhi, India (2014).

Reviewer:

1. Inorganic Chemistry

2. Dalton Transactions

3. RSC Advances

4. Applied Organometallic Chemistry

5. New Journal of Chemistry

6. European Journal of Medicinal Chemistry

7. International Journal of Biological Macromolecules

8. Journal of Coordination Chemistry

9. Spectroscopy Letters

10. Archiv di pharmie

11. Chirality

12. Journal of Applied Organometallic Chemistry

13. Journal of Photochemistry and Photobiology B: Biology

14. Nucleosides, Nucleotides, and Nucleic Acids

15. Molecular Biosystems

16. Peer Reviewer for DBT, New Delhi sponsored research proposals.

PUBLICATIONS:

5

1. Cu/Na Heteronuclear complex Of Schiff base derived from o-vanilline: Evaluation

of DNA binding/cleavage, cell viability, apoptosis and genotoxicity, Sartaj

Tabassum, Ali Alsalme, Farukh Arjmand, Hammad A. AlLohedan, Khalid

Mashay Al-Anazi, Mohammad Usman, Mohammad Abul Farah, Mohd. Sajid Ali,

Musheer Ahmad, Rais Ahmad Khan. Inorg. Chim. Acta, 2018 (Accepted).

2. New tailored substituted‒benzothiazole Schiff base Cu(II)/Zn(II) antitumor drug

entities: Effect of substituents on DNA binding profile, antimicrobial and cytotoxic

activity. Siffeen Zehra, Mohammad Shavez Khan, Iqbal Ahmad and Farukh

Arjmand. Journal of Biomolecular Structure and Dynamics. 2018 (Accepted)

3. Single X-ray crystal structure, DFT studies and topoisomerase I inhibition activity

of a tailored ionic Ag(I) nalidixic acid–piperazinium drug entity specific for

pancreatic cancer cells. Imtiyaz Yousuf, Mohammad Usman, Musheer Ahmad,

Sartaj Tabassum and Farukh Arjmand, New J. Chem., 42 (2018) 506–519.

4. Synthesis, characterization, in vitro cytotoxicity and DNA interaction study of

phosphanegold(I) complexes with dithiocarbamate ligands, Said S. Al-Jaroudi,

Muhammad Altaf, Adam A. Seliman, Shipra Yadav, Farukh Arjmand, Ali

Alhoshani, H.M. Korashy, Saeed Ahmad, Anvarhusein A. Isab, Inorg. Chim. Acta,

464 (2017) 37–48.

5. De novo design of hydrolytic DNA cleavage agent, mono nitratobis(phen)cobalt(II)

aqua nitrate complex, Surbhi Sharma, Loïc Toupet and Farukh arjmand, New J.

Chem., 2017, 41, 2883-2886 .

6. Heteroleptic Copper(I) Complexes of “Scorpionate” Bis-pyrazolyl Carboxylate

Ligand with Auxiliary Phosphine as Potential Anticancer Agents: An Insight into

Cytotoxic Mode , Rais Ahmad Khan, Mohammad Usman, Dhivya Rajakumar,

Perumalsamy Balaji, Ali Alsalme, Hamad Al-Lohedan, Farukh Arjmand, Khalid

Al Farhan, Mohammad Abdulkader Akbarsha, Fabio Marchetti, Claudio Pettinari,

and Sartaj Tabassum, Nature Sci. Rep., 2017, 7:45229, 1-17 | DOI:

10.1038/srep45229.

7. Synthesis of chiral R/S-pseudopeptide-based Cu(II) & Zn(II) complexes for use in

targeted delivery for antitumor therapy: enantiomeric discrimination with CT-DNA

and pBR322 DNA hydrolytic cleavage mechanism, Sabiha Parveen, Sartaj

Tabassum and Farukh Arjmand, RSC Adv., 2017, 7, 6587-6597.

8. Chiral transition metal complexes: Synthetic approach and biological

applications, Surbhi Sharma, Mala Chauhan, A. Jamsheera, Sartaj Tabassum,

Farukh Arjmand, Inorg. Chim. Acta, 458 (2017) 8–27.

9. In vitro DNA binding profile of enantiomeric dinuclear Cu(II)/Ni(II)

complexes derived from L–/D–histidine–terepthaldehyde reduced Schiff

base as potential chemotherapeutic agents, Imtiyaz Yousuf and Farukh Arjmand,

J. Photochem. Photobiol. B, 164 (2016) 83–95.

10. Human Topoisomerase I mediated cytotoxicity profile of L-valine quercetin

diorganotin(IV) antitumor drug entities, Sabiha Parveen, Sartaj Tabassum, Farukh

Arjmand, J. Organomet. Chem. 823 (2016) 23-33.

11. Synthesis, characterization, crystal structure of RNA targeted L- and D-

phenylalanine-(1, 10-phen)-copper(II) conjugate complexes; Comparative in vitro

RNA binding profile of enantiomers and their biological evaluation by

6

morphological studies and antibacterial activity, Surbhi Sharma, Loïc Toupet,

Musheer Ahmad and Farukh Arjmand, RSC Adv., 2016, 6, 79372.

12. A comparative analyses of bioactive Cu(II) complexes using Hirshfeld surface and

density functional theory (DFT) methods: DNA binding studies, cleavage and

antibiofilm activities, Mohammad Usman, Farukh Arjmand, Musheer Ahmad,

Mohammad Shavez Khan, Iqbal Ahmad, Sartaj Tabassum, Inorg. Chim. Acta,

2016, 453, 193–201. 13. Vibrational dynamics (IR, Raman, NRVS) and a DFT study of a new antitumor

tetranuclearstannoxane cluster, Sn(IV)-oxo-{di-o-vanillin} dimethyl dichloride,

Farukh Arjmand, Surbhi Sharma, Mohammad Usman, B. M. Leu, M.Y. Hu, Loic

Toupet, D. gosztola and Sartaj Tabassum, Phys. Chem. Chem. Phys., 2016, 18,

17805-17809.

14. Current and future potential of metallo drugs: Revisiting DNA-binding of metal

containing molecules and their diverse mechanism of action, Mehvash Zaki, Farukh

Arjmand, Sartaj Tabassum, Inorg. Chim. Acta, 2016, 44, 1-22.

15. A dinuclear copper(II) complex with piperazine bridge ligand as a potential

anticancer agent: DFT computation and biological evaluation Waddhaah M. Al-

Asbahy, Mohammad Usman, Farukh Arjmand, Manal Shamsi, Sartaj Tabassum,

Inorg. Chim. Acta, 445 (2016) 167–178.

16. Non-covent investigation of superparamagnetic Fe3O4@SWBNNTs core-shell,

Taghipour, M; Kondabey, J; Arjmand, F; EbrahimiMokaram, E; Behravan, M;

Dodangeh, F; Nozari, M; Ahangaran, E; Fereidouni, F; Najaflou, R; Hashemi, Z;

Yousefi, A; Monajjemi, Majid J. Comput Theor Nanosci, 13(7):4722-4729. ·

17. Synthesis and characterization of Co(II) and Fe(II) peptide conjugates as hydrolytic

cleaving agents and their preferential enantiomeric disposition for CT–DNA:

Structural investigation of L–enantiomers by DFT and molecular docking studies.

Sabiha Parveen, Mohammad Usman, Sartaj Tabassum and Farukh Arjmand,

RSC Adv., 2015, 5, 72121-72131.

18. Synthesis and spectroscopic characterization of diorganotin(IV) complexes of N'-

(4-hydroxypent-3-en-2-ylidene)isonicotinohydrazide: Chemotherapeutic potential

validation by in vitro interaction studies with DNA/HSA, DFT, molecular docking

and cytotoxic activity. Shipra Yadav, Imtiyaz Yousuf, Mohammad Usman,

Musheer Ahmad, Farukh Arjmand, and Sartaj Tabassum. RSC Adv., 2015, 5,

50673-50690.

19. Mechanistic insights of a novel chromone -appended Cu(II) anticancer drug entity:

In vitro binding profile with DNA/RNA substrates and cytotoxic activity against

MCF-7 and HepG2 cancer cells. Imtiyaz Yousuf, Farukh Arjmand, Sartaj

Tabassum, Loic Toupet, Rais Ahmad Khan, Abdulaziz A. Al-Khedhairy. Dalton

Trans., 2015, 44, 10330–10342.

20. Crystal structure determination, spectroscopic characterization and biological

profile of tailored antitumor ionic drug entity, Sn(IV) iminodiacetic

acidpiperazinediium conjugate: In vitro DNA and RNA binding Studies, Topo I

inhibition, cytotoxic activity and systemic toxicity studies. Farukh Arjmand,

Imtiyaz Yousuf, Yusra Zaidi and Loic Toupet, RSC adv., 2015, 5, 16250–16264.

7

21. Enantiomeric fluoro–substituted benzothiazole Schiff base–valine Cu(II)/Zn(II)

complexes as chemotherapeutic agents: DNA binding profile, cleavage activity,

MTT assay and cell imaging studies. Rahman Alizadeh, Imtiyaz Yousuf, Mohd

Afzal, Saurabh Srivastav, Saripella Srikrishna, Farukh Arjmand, J. Photochem.

Photobiol. B: Biol. 143, 61–73, (2015).

22. Research for the benefit of Humanity: Role of metal based chemotherapeutic

entities in cancer, Farukh Arjmand, University News. 52, 31–32, (2014).

23. Exploration of glycosylated–organotin(IV) complexes as anticancer drug

candidates. Sartaj Tabassum, Shipra Yadav, Farukh Arjmand, Inorg. Chim. Acta,

423, 38–45, (2014).

24. Organo-tin Antitumor Compounds: Their Present Status in Drug Development and

Future Perspectives.Farukh Arjmand, Sabiha Parveen, Sartaj Tabassum, Claudio

Pettinari, Inorg. Chim. Acta, 423, 26–37 (2014).

25. Synthesis and crystal structure determination of copper(II)-complex: In vitro DNA

and HSA binding, pBR322 plasmid cleavage, cell imaging and cytotoxic studies.

Sartaj Tabassum, Mehvash Zaki, Mohd. Afzal, Musheer Ahmad, Saurabh Srivastav,

Saripella Srikrishna and Farukh Arjmand, Eur. J. Med. Chem., 83 141−154

(2014).

26. Organometallic Ruthenium(II) Scorpionate as Topo II inhibitor; in vitro Binding

Studies with DNA, HPLC Analysis and its Anticancer Activity. Rais Ahmad Khan,

Farukh Arjmand, Sartaj Tabassum, Magda Monari, Fabio Marchetti, Claudio

Pettinari, J. Organomet. Chem. 71, 47−58, (2014).

27. Design and synthesis of new Zn(II) nalidixic acidDACH based Topo−II inhibiting

molecular entity: Chemotherapeutic potential validated by its in vitro binding

profile, pBR322 cleavage activity and molecular docking studies with DNA and

RNA molecular targets. Farukh Arjmand, Imtiyaz Yousuf, Mohd. Afzal and Loic

Toupet. Inorg. Chm. Acta. 421, 26–37, (2014).

28. Synthesis, crystal structure and antiproliferative activity of Cu(II) nalidixic

acidDACH conjugate: Comparative in vitro DNA/RNA binding profile, cleavage

activity and molecular docking studies. Farukh Arjmand, Imtiyaz Yousuf, Taibi

Ben Hadda and Loic Toupet, Eur. J. Med. Chm. 81, 7688, (2014).

29. Design and Synthesis of Enantiomeric (R)– and (S)–Copper(II) and

diorganotin(IV)−based antitumor agents: Their in vitro DNA binding profile,

cleavage efficiency and cytotoxicity studies. Farukh Arjmand, Mohd. Muddassir,

Imtiyaz Yousuf, J. Photochem. Photobiol. B, 136, 62–71, (2014).

30. Synthesis and characterization of new transition metal {Cu(II), Ni(II) and Co(II)}

L–phenylalanine–DACH conjugate complexes: In vitro DNA binding, cleavage and

molecular docking studies. Manal Shamsi, Shipra Yadav, Farukh Arjmand, J.

Photochem. Photobiol. B 136, 1–11, (2014).

31. In vitro DNA binding, pBR322 plasmid cleavage and molecular modeling study of

chiral benzothiazole Schiff–base–valine Cu(II) and Zn(II) complexes to evaluate

their enantiomeric biological disposition for molecular target DNA. Rahman

Alizadeh, Mohd Afzal, Farukh Arjmand, Spectrochimica Acta A, 131, 625–635,

(2014).

8

32. A Comprehensive biological insight of trinuclear Copper(II)tin(IV)

chemotherapeutic anticancer drug entity: in vitro cytotoxicity and in vivo systemic

toxicity studies. Yusra Zaidi, Farukh Arjmand, Nida Zaidi, Jawed Usmani,

Haseeb Zubair, Kafil Akhtar, Mobarak Hossain, G. G. Hammad Shadab,

Metallomics, 6, 1469-1479, (2014).

33. Synthesis and characterization of Cu(II)based anticancer chemotherapeutic agent

targeting topoisomerase Iα: In vitro DNA binding, pBR322 cleavage, molecular

docking studies and cytotoxicity against human cancer cell lines. Sartaj Tabassum,

Mehvash Zaki, Mohd. Afzal, Farukh Arjmand, Eur. J. Med. Chem., 74,

509523, (2014). 34. Enantiomeric in vitro DNA binding, pBR322 DNA cleavage and molecular docking

studies of chiral Land Dternary copper(II) complexes of histidine and picolinic

acid. Shazia Parveen, Farukh Arjmand, J. Photochem. Photobiol. B, 130 170–

178, (2014).

35. New modulated design, docking and synthesis of carbohydrate-conjugate

heterobimetallic CuII-SnIV complex as potential topoisomerase II inhibitor: In vitro

DNA binding, cleavage and cytotoxicity against human cancer cell lines, Sartaj

Tabassum, Mohd Afzal, Farukh Arjmand, Eur. J. Med. Chem., 74,

694−702,(2014).

36. Carbohydrate Linked Organotin(IV) Complexes as Human Topoisomerase Iα

Inhibitor and their Antiproliferative Effects Against Human Carcinoma Cell Line. Rais Ahmad Khan, Shipra Yadav, Zahid Hussain, Farukh Arjmand and Sartaj

Tabassum, Dalton Trans., 43, 2534–2548, 2014.

37. Chiral heterobimetallic complexes targeting human DNA-topoisomerase Iα.Sartaj

Tabassum, Ahmad Asim, Rais Ahmad Khan, Zahid Hussain, Saurabh Srivastav,

Saripella Srikrishna and Farukh Arjmand, Dalton Trans., 42, 16749-16761,

(2013).

38. Ligand dependent self-assembly of hydroxido-bridged dicopper units templated by

sodium ion. Avijit Sarkar, Alok Ranjan Paital, Rais Ahmad Khan, Farukh

Arjmand, Valerio Bertolasi, Corine Mathonière, Rodolphe Clérac and Debashis

Ray, Dalton Trans., 42, 12495-12506, (2013).

39. Synthesis and mechanistic insight of glycosylated CuII / NiII–Sn2IV

heterobimetallic DNA binding agents: Validation of a specific CuII–Sn2IV

chemotherapeutic agent for human leukemic cell line K–562. Sartaj Tabassum,

Shipra Yadav, Farukh Arjmand, J. Organomet. Chem. 745-746, 226-234 (2013).

40. Chiral discrimination of metal–based chemotherapeutics Co(II), Cu(II) and Zn(II)

towards the ultimate drug target–DNA. Farukh Arjmand, Shazia Parveen, Sabiha

Parveen, Mohd. Afzal, Chemistry & Biology Interface 3, 137-145, (2013).

41. In vitro DNA binding profile and antimicrobial studies of chromone Schiff base organotin(IV) complexes.Farukh Arjmand, Imtiyaz Yousuf, J. Organomet.

Chem. 743, 55–62, (2013).

42. Zinc(II) complexes of Pro-Gly and Pro-Leu dipeptides: Synthesis, characterization,

in vitro DNA binding and cleavage studies. Farukh Arjmand, Shazia Parveen,

D.K. Mohapatra, J. Photochem. Photobiol. B, 126, 78–86, (2013).

9

43. New modulated design and synthesis of quercetin–CuII/ZnII–Sn2IV scaffold as

anticancer agents: in vitro DNA binding profile, DNA cleavage pathway and Topo–

I activity.Sartaj Tabassum, Mehvash Zaki, Mohd. Afzal, Farukh Arjmand, Dalton

Trans., 42, 10029, (2013).

44. A Chloro-Bridged Heterobimetallic (η6–Arene)ruthenium−Organotin Complex as

an Efficient Topoisomerase Iα Inhibitor.Rais Ahmad Khan, Ahmad Asim, Rita

Kakkar, Deepti Gupta, Vivek Bagchi, Farukh Arjmand, Sartaj Tabassum,

Organometallics 32, 2546−2551, (2013).

45. Design and synthesis of S– and R– enantiomers of [4–(2–hydroxy–1–

phenylethylimino)pent–2–ol]dimethyltin(IV) and 2,2–dimethyl–4–phenyl–1,3,2–

oxazastannolidine: In vitro and in vivo antitumor activity of their S–enantiomer

against human tumor cell lines. Farukh Arjmand, Fatima Sayeed, Shazia Parveen,

Sartaj Tabassum, Aarti S. Juvekar, Surekha M. Zingde, Dalton Trans. 42, 3390–

3401 (2013).

46. Design, synthesis and crystal structure determination of dinuclear copper–based

potential chemotherapeutic drug entity; in vitro DNA binding, cleavage studies

and an evaluation of genotoxicity by micronucleus test and comet assay. Farukh

Arjmand, Mohd. Muddassir, Yusra Zaidi, Debashis Ray, Med Chem Comm 4, 394

–405 (2013).

47. Synthesis, DNA recognition and cleavage studies of novel tetrapeptide complexes,

Cu(II)/Zn(II)–Ala–Pro–Ala–Pro.Farukh Arjmand, A. Jamsheera, D.K. Mohapatra,

Spectrochimica Acta A,108, 151–158 (2013).

48. Synthesis, characterization and in vitro DNA binding and cleavage studies of

Cu(II)/Zn(II) dipeptide complexes. Farukh Arjmand, A. Jamsheera, D.K.

Mohapatra, J. Photochem. Photobiol. B, 121, 75–85 (2013).

49. Antitumor activity of tin complexes. Invited contribution, Encyclopedia of

Metalloproteins, Springer (2012).

50. Synthesis and characterization of copper(II) and zinc(II)- based potential

chemotherapeutic compounds: Their biological evaluation viz. DNA binding

profile, cleavage and antimicrobial activity. S. Tabassum, A. Asim, F. Arjmand,

M. Afzal, V. Bagchi, Eur. J. Med. Chem., 58, 308−316 (2012).

51. Mixed-Ligand Cu(II)-Vanillin Schiff Base Complexes; Effect of Coligands on

their DNA Binding, DNA Cleavage, SOD Mimetic and Anticancer Activity. S.

Tabassum, S. Amir, F. Arjmand, C. Pettinari, F. Marchetti, N. Masciocchi, G.

Lupidi, R. Pettinari, Eur. J. Med. Chem., 60, 216−232 (2013).

52. Synthesis of heterobimetallic complexes: in vitro DNA binding, cleavage and

antimicrobial studies. Sartaj Tabassum, Mehvash Zaki, Farukh Arjmand, Iqbal

Ahmad, J. Photochem. Photobiol. B 114, 108–118 (2012).

53. Interaction and Photo–induced Cleavage Studies of Copper based

Chemotherapeutic Drug with Human Serum Albumin: Spectroscopic and Molecular

Docking Study. Sartaj Tabassum, Waddhaah M. Al–Asbahy, Mohd. Afzal, Farukh

Arjmand and Rizwan Hasan Khan, Mol. BioSyst., 8, 2424−2433 (2012).

54. Synthesis, characterization and interaction studies of copper based drug with Human Serum Albumin (HSA): Spectroscopic and molecular docking

10

investigations. Sartaj Tabassum, Waddhaah M. Al-Asbahy, Mohd. Afzal, Farukh

Arjmand, J. Photochem. Photobiol. B: Biol. 114, 132–139, (2012).

55. DNA binding and cleavage studies of new sulfasalazine-derived dipeptide Zn(II)

complex: Validation for specific recognition with 5′–TMP. Sartaj

Tabassum, Waddhaah M. Al–Asbahy, Mohd. Afzal, Manal shamsi, Farukh

Arjmand, J. Lumin., 132, 3058–3065 (2012).

56. Enantiomeric recognition of chiral L– and D–penicillamine Zinc(II) complexes:

DNA binding behavior and cleavage studies. Farukh Arjmand, Shazia Parveen,

RSC Advances, 2, 6354–6362, (2012).

57. Synthesis, characterization, biological studies (DNA binding, cleavage, antibacterial

and topoisomerase I) and molecular docking of copper(II) benzimidazole

complexes.Farukh Arjmand, Shazia Parveen, Mohd. Afzal, Mohd. Shahid, J.

Photochem. Photobiol. B: Biol. 114, 15–26, (2012).

58. Molecular drug design, synthesis and structure elucidation of a new specific target

peptide based metallo drug for cancer chemotherapy as topoisomerase I

inhibitorSartaj Tabassum, Waddhaah M. Al-Asbahy, Mohd. Afzal, Farukh

Arjmand, Vivek Bagchi, Dalton Trans., 41(16), 4955–4964, (2012).

59. Enantiomeric specificity of biologically significant Cu(II) and Zn(II) chromone

complexes towards DNA. Farukh Arjmand, A. Jamsheera, Mohd. Afzal and

Sartaj Tabassum, Chirality 24, 977-986, (2012).

60. Design, synthesis, characterization and DNA–binding studies of a triphenyltin(IV)

complex of N–glycoside (GATPT), a sugar based apoptosis inducer: in vitro and in

vivo assessment of induction of apoptosis by GATPT. Sartaj Tabassum , Suvigya

Mathur, Farukh Arjmand, Kanchan Mishra and Kakoli Banerjee, Metallomics, 4,

205–217 (2012).

61. New modulated design and synthesis of chiral CuII/SnIV bimetallic potential

anticancer drug entity: in–vitro DNA binding and pBR322 DNA cleavage

activity. Sartaj Tabassum, Girish Chandra Sharma and Farukh Arjmand,

Spectrochimica Acta Part A, 90, 208-217 (2012).

62. Synthesis, Characterization of Cu(II) and Zn(II) complexes of Proline–Glycine and

Proline–Leucine tetrapeptides: in vitro DNA binding and cleavage studies.Farukh

Arjmand, Shazia Parveen and D.K. Mohapatra, Inorg. Chim. Acta 388, 1-10

(2012)

63. Molecular drug design, synthesis and crystal structure determination of CuII–

SnIV heterobimetallic core: DNA binding and cleavage studies. Farukh Arjmand,

Shazia Parveen, Mohd. Afzal, Loic Toupet and Taibi Ben Hadda, Eur. J. Med.

Chem. 49, 141–150 (2012).

64. De novo design, synthesis and spectroscopic characterization of chiral

benzimidazole–derived amino acid Zn(II) complexes: Development of tryptophan–

derived specific hydrolytic DNA artificial nuclease agent. Shazia Parveen and

Farukh Arjmand, Spectrochim. Acta Part A: 85, 53–60 (2012).

65. In–vitro DNA binding and cleavage studies with pBR322 of N,N–Bis(3β–acetoxy–

5α–cholest–6–yl–idene)hydrazine (L). Zishan Tabassum, Mohd Muddassir,

Othman Sulaiman and Farukh Arjmand, J. Lumin. 132, 2178–2181(2012).

11

66. Carbohydrate–conjugate heterobimetallic complexes: synthesis, DNA binding

studies, artificial nuclease activity and in –vitro cytotoxicity. Sartaj Tabassum, Rais

Ahmad Khan, Farukh Arjmand, Mubashira Aziz, Aarti S. Juveka, Subrata Sen

and Surekha M. Zingde, Carbohydrate Research, 346,2886–2895 (2011).

67. Design and synthesis of new metal based potent chemotherapeutic agents derived

from 3–acetoacetyl–7–methyl–pyrano–[4,3–b]–pyran–2,5–dione: DNA binding

profile and in vitro cytotoxic activity against different human cancer cell lines.

Farukh Arjmand and Mubashira Aziz, Chem. Biol. Interface 1, 1, 135–160

(2011).

68. Synthesis of Diketo Copper(II) Complex and Its Binding toward Calf Thymus DNA

(CT-DNA). Aijaz Ahmad Tak and Farukh Arjmand, J. Kor.Chem. Soc. 55, 177–

182 (2011).

69. In vitro binding studies of organotin(IV) complexes of 1,2–Bis(1H–benzimidazol–

2–yl)ethane–1,2–diol with CT–DNA and nucleotides (5′–GMP and 5′–TMP): Effect

of the ancillary ligand on the binding propensity. Farukh Arjmand, Fatima Sayeed

and Shazia Parveen, J. Organomet. Chem. 696, 3836 –3845 (2011).

70. Synthesis, characterization and in vitro DNA binding studies of Tin(IV)

complexes of tert–butyl 1–(2–hydroxy–1–phenylethylamino)–3–methyl–1–

oxobutan–2–yl carbamate. Farukh Arjmand and Jamsheera A, J. Organomet.

Chem. 696, 3572-3579 (2011).

71. De novo design of chiral organotin cancer drug candidates: validation of

enantiopreferential binding to molecular target DNA and 5’–GMP by UV–visible,

Fluorescence, 1H and 31P NMR. Farukh Arjmand, Girish Chandra Sharma, Fatima

Sayeed, Mohd. Muddassir and Sartaj Tabassum, J. Photochem. Photobiol. B: Biol.

105, 167–174 (2011).

72. Synthesis of new chiral heterocyclic Schiff base modulated Cu(II)/Zn(II)

complexes: their comparative binding studies with CT–DNA, mononucleotides

and cleavage activity. Farukh Arjmand, Fatima Sayeed Mohd.. Muddassir, J.

Photochem. Photobiol. B: Biol., 103, 166–179, (2011).

73. Synthesis and Characterization of Glycoconjugate Tin(IV) Complexes: in vitro

DNA Binding Studies, Cytotoxicity, and Cell Death.mSartaj Tabassum, Rais

Ahmad Khan, Farukh Arjmand, Subrata Sen, Jyoti Kayal, Aarti S. Juvekar and

Surekha M. Zingde. J. Organomet. Chem. 696, 1600–1608 (2011).

74. Cyclic Voltammetry–An Electrochemical Approach to Study Metal–based

Potential Antitumor Drug–DNA Interaction. Farukh Arjmand, Mubashira Aziz

and Sartaj Tabassum Curr. Anal. Chem. 7, 71, (2011).

75. Synthesis and enantiopreferential DNA binding profile of late 3d transition metal

R– and S–enantiomeric complexes derived from N, N–bis–(1–benzyl–2–

ethoxyethane): Validation of R– enantiomer of copper(II) complex as a

humantopoisomerase II inhibitor.Farukh Arjmand, Girish Chandra Sharma,

Mohd. Muddassir and Sartaj Tabassum, Chirality, 23, 557–567, (2011).

76. DNA Binding Studies of New Valine Derived Chiral Complexes of Tin(IV) and

Zirconium(IV).F. Arjmand and Jamsheera A, Spectro. Chim. Acta. A 78, 45,

(2011).

12

77. A mechanistic approach for the DNA binding of chiral enantiomeric L- and D-

tryptophan-derived metal complexes of 1,2-DACH: cleavage and antitumor

activity.F. Arjmand and M. Muddassir, Chirality, 23, 250 (2011).

78. Design and Synthesis of heterobimetallic topoisomerese I and II inhibitor

complexes: in vitro DNA binding, interaction with 5′–GMP and 5′–TMP and

cleavage studies. F. Arjmand, and M. Muddassir, J. Photochem. Photobiol. B:

Biol. 101, 37, (2010).

79. DNA interaction studies of new nano metal based anticancer agent: validation by

spectroscopic methods. S. Tabassum, G.C. Sharma, F. Arjmand and A. Azam,

Nanotechnology, 21, 195102, (2010).

80. Chiral preference of L–tryptophan derived metal–based antitumor agent of late 3d–

metal ions (Co(II), Cu(II) and Zn(II)) in comparison to D and DL–tryptophan

analogues: Their in–vitro reactivity towards CT DNA, 5'–GMP and 5'–TMP.F.

Arjmand, M. Muddassir and R.H. Khan, Eur. J. Med. Chem, 45(9), 3549, (2010).

81. Synthesis, Characterization and DNA binding studies of mono and

heterobimetallic complexes Cu–Sn2/Zn–Sn2 and their cleavage activity with

pBR322 plasmid DNA. F. Arjmand and F. Sayeed, J. Mol. Struct., 965, 14 (2010).

82. Synthesis of carbohydrate conjugates heterobimetallic CuII–Sn2IV and ZnII–Sn2

IV

complexes; their interactions with CTDNA and nucleotides; DNA cleavage and in

vitro cytotoxicity. Sartaj Tabassum, R.A. Khan, F. Arjmand, A.S. Juvekar and

S.M. Zingde. Eur. J. Med. Chem., 45, 4797 (2010).

83. Interaction studies of a novel Co(II) based potential chemotherapeutic agent with

human serum albumin (HSA) employing biophysical techniques. F. Arjmand, P.

Tewatia, M. Aziz and R.H. Khan, Med. Chem. Res. 19, 794 (2010).

84. Synthesis and biophysical studies of bis–macrocyclic cobalt/copper (II) complexes

having pyridine spacer with CT DNA and 5’ GMP.F. Arjmand and M. Aziz,

Chemistry and Biodiversity, 6, 2275 (2009).

85. Interaction with DNA of a heteronuclear [Na2Cu4] coordination cluster obtained

from the assembly of two hydroxo–bridged [CuII2] units by a dimeric sodium nitrate

template. D. Mandal, M. Chauhan, F. Arjmand, G. Aromí and D. Ray, Dalton.

Trans, 9183 (2009).

86. Synthesis of new heterometallic macromolecules: Their DNA–binding, cleavage

activity and in vitro model electrochemotherapy study. S. Tabassum, I.–u.–Haq

Bhat and Farukh Arjmand, Spectrochim. Acta. A, 74 1152 (2009).

87. Synthesis and characterization of dinuclear macrocyclic cobalt(II), copper(II) and

zinc(II) complexes derived from 2,2,2′,2′-S,S[bis(bis-N,N-2-

thiobenzimidazolyloxalato-1,2-ethane)]: DNA binding and cleavage studies. F.

Arjmand and M. Aziz, Eur. J. Med. Chem., 44, 834 (2009).

88. Synthesis, Spectroscopic Studies of New Water–Soluble Co(II) and Cu(II)

Macrocyclic complexes of 4,15–bis(2–hydroxyethyl)–2,4,6,13,15,17–

hexaazatricyclodocosane:Their Interaction Studies with Calf Thymus DNA and

Guanosine 5’ Monophosphate.F. Arjmand, M. Aziz and M. Chauhan, J. Inclusion

Phenom. Macrocyclic Chem., 61, 265 (2008).

13

89. Stannoxane capping derived from chiral tridentate NNO donor ligand for nickel

and copper macrocycles: Comparative binding studies of stannoxane moiety and its

modulated copper complex with CT DNA. M. Chauhan and F. Arjmand, J.

Organomet. Chem. 692, 5156 (2007).

90. DNA binding studies of novel copper (II) complexes containing L–tryptophan as

chiral auxiliary: In vitro antitumor activity of Cu–Sn2 complex in human

neuroblastoma cells. M. Chauhan, K. Banerjee and F. Arjmand, Inorg. Chem. 46,

3072 (2007).

91. Chiral and achiral macrocyclic copper (II) complexes: synthesis, characterization

and comparative binding studies with calf thymus DNA. M. Chauhan and F.

Arjmand, Chemistry & Biodiversity, 3(6), 660 (2006).

92. Cu(II) complexes as receptor molecules for development of new chloride

sensors.R.K.Mahajan, R. Kaur, S. Tabassum, F. Arjmand, and Suvigya Mathur,

Electrochimica Acta; 52, 408 (2006).

93. New dihydro OO bis(salicylidene)2,2aminobenzothiozolyl borate complexes:

Kinetic and voltammetric studies of dimethyltin copper complex with guanine,

adenine and calf thymus DNA. F. Arjmand, B. Mohani and S. Parveen, Bioinorg.

Chem. Appl., Article ID 32896, 1–10 (2006).

94. Synthesis of O,O–ethylene bridged bis–copper(II) macrocycles: Selective enzyme

models for catecholase activity. F. Arjmand, S. Parveen, M. Chauhan, S. Parveen,

and S. Tabassum, Trans. Met. Chem, 31, 237 (2006).

95. Synthesis, antibacterial, antifungal activity and interaction of CT–DNA with a new

bezimidazole derived Cu(II) complex. F. Arjmand, B. Mohani and S. Ahmad, Eur.

J. Med. Chem., 40, 1103 (2005).

96. Binding studies of asymmetric pentacoordinate Cu(II) complexes containing

phenanthroline and ethylenediamine moiety with calf thymus DNA. F. Arjmand

and M. Chauhan, Helvetica Chimica Acta., 88, 2413 (2005).

97. New modulated metallic macrocycles: Electrochemistry and their interaction with

calf thymus DNA.S. Tabassum, S. Parveen and F. Arjmand, Acta Biomaterialia;

1, 677 (2005).

98. Interaction of calf thymus DNA with new asymmetric copper(II) N,N–ethane

bridged N2S2 macrocycle. S. Parveen and F. Arjmand, Indian J. Chem. 44A, 1151

(2005).

99. Synthesis, characterization and interaction of a new chiral trinuclear complex

[bis(aquodiaminotryptophanato)CuII–Sn2IV] chloride with calf thymus DNA. M.

Chauhan and F. Arjmand, Trans. Met. Chem, 30, 481 (2005).

100. Synthesis and characterization of new synthetic oxygen carriers. A kinetic studies

of the reaction of the binuclear iron(III) and copper(II) complex with H2O2.S.

Tabassum, S. Parveen and F. Arjmand, Trans. Met. Chem, 30, 196 (2005).

101. Synthesis of new dinuclear dicopper(II) and dinickel(II) complexes: Kinetics of

catechol oxidase and electrochemistry of dicopper(II) complex. F. Arjmand, S.

Parveen and S. Tabassum, Trans. Met. Chem, 30, 128 (2005).

14

102. Template synthesis of CoII, NiII and CuII complexes derived from oxamide ligand

and the reactivity of CuII complex towards Human Serum Albumin. B.Mohani and

F. Arjmand, Bioinorg. Chem. Appl. 2, 225 (2004).

103. New binuclear oxygen carriers of the type [M–mac–M’(L)4]Cl2.(ClO4)2 where

M–mac = Co(II) and Ni(II) 1,8–dihydro–1,3,6,8,10,13–hexaazacyclotetradecane

M= Mn(II), Ni(II), Cu(II) and L= tetra(3–acetyl pyridine) and their kinetic studies

with H2O2.S. Tabassum, S. Parveen, and F. Arjmand, Indian J. Chem. 43A, 270

(2004).

104. Synthesis of new five coordinated copper(II) and nickel(II) complexes of

L‒valine and kinetic study of copper(II) with calf thymus DNA. A.A. Tak, F.

Arjmand and S. Tabassum, Metal Based Drugs. 9(1-2), 81 (2002).

105. Synthesis, characterization of novel macrocycles and their complexes with

transition metal ions. S. Tabassum, S. H. Rafiqi and F. Arjmand, Synth. React.

Inorg. Met. Org. Chem. 32, 949 (2002).

106. New metal compounds and their reactivity towards bovine milk casein.B.

Mohani, F. Arjmand and S. Tabassum, Trans. Met. Chem. 27, 776 (2002).

107. Synthesis, characterization, electrochemistry and kinetics of CTDNA binding of

a bis ciprofloxacin borate copper(II) complex.A.A. Tak, F. Arjmand and S.

Tabassum, Trans. Met. Chem. 27, 741 (2002).

108. Interaction of a new cobalt (II) complex of 5–coordinated chiral porphyrin with

calf thymus DNA.S. Tabassum, F. Athar and F. Arjmand, Trans. Met. Chem. 27,

256 (2002).

109. Synthesis, characterization and toxicity of heterobinuclear complexes of transition

metal ions.S. Tabassum, N. P. Singh and F. Arjmand, Synth. React. Inorg.

Met. Org.Chem . 31 , 1803 (2001).

110. Synthesis and characterization of heterobimetallic complexes of

1,8–dihydro– 1,3,6,8,10,13 Hexaazacyclotetradecane with Cu(II), Ni(II), Si(IV),

Ge (IV) and Sn(IV)Chlorides.S. Tabassum, S. H. Rafiqi, N. Nishat, F. Arjmand

and S. Srivastava. Indian J. Chem. 40(A), 1237 (2001).

111. Novel asymmetric heterobimetallic complexes of transition metals and kinetics of

oxygen binding to cobalt (II) complex. F. Athar, F. Arjmand and S. Tabassum,

Trans. Met. Chem. 26, 574 (2001).

112. New asymmetric N2S2 macrocycles, their metal chelates and the photokinetics of

DNA–complex interaction. F. Athar, F. Arjmand and S. Tabassum, Trans. Met.

Chem. 26, 426 (2001).

113. Synthesis and characterization of novel chiral organotin complexes.F. Arjmand

and F. Athar, Indian J. Chem. 40A, 213 (2001).

114. Synthesis and characterization of lanthanides chelates with metal containing

ligands. S. Tabassum, A. Bashar, F. Arjmand and K. S. Siddiqi, Synth. React.

Inorg. Met. Org. Chem. 27(4), 487 (1997).

115. Reactivity of sulpha drug metal complexes with group (IV) metal halides and

some bioactive organic bases. S. Tabassum, F. Arjmand, S. H. Rafiqi and

Lutfullah, Main Group Met. Chem. 19, 245 (1996).

15

116. Synthesis of new 14 and 16 membered macrocycles and their transition metal

complexes. S. Tabassum, N. Nishat, F. Arjmand, Lutfullah and K. S. Siddiqi,

Trans. Met. Chem. 21, 97 (1996).

117. Chelating behaviour of new 12–membered Schiff base macrocycles containing

pendant groups. S. Tabassum, N. Nishat, S. A. A. Zaidi and F. Arjmand, Trans.

Met. Chem. 20, 13 (1995).

118. Schiff base complexes as ligand: Bimetallic chelates of M(SBH2)Cl2 with

Group(IV) metal tetrachlorides. K.S. Siddiqi, F. Arjmand, S. Tabassum and S. A.

A. Zaidi, Synth. React. Inorg. Met. Org. Chem., 25, 955 (1995).

119. Heterobimetallic complexes of novel N2S2 macrocyclic ligands with Group(IV)

tetrachlorides and bis(trimethylsilyl) amine.F. Arjmand, S. Tabassum, S. A. A.

Zaidi and K. S. Siddiqi, Main Group Met. Chem. 17, 619 (1994).

120. N2S2 macrocyclic ligands: Synthesis and characterization of novel transition metal

complexes of the type [LM(Si2Me6NH2)] and [LM(Si2Me6NH2)].K.S. Siddiqi, F.

Arjmand, S. Tabassum and S. A. A. Zaidi, Trans. Met. Chem. 19, 399 (1994).

121. Novel heterobimetallic chelates: Condensation of (3–acetoacetyl–7−methyl–

pyrano–(4,4–b)–pyran–2, 5–dione) with bis 1,3–diamino propane Cu(II) chloride

and group(IV) metal tetrachlorides.K.S. Siddiqi, F. Arjmand, Mujeeb–ur–Rehman,

S. Tabassum and S. A. A. Zaidi,J. Chem. Res. (S), J. Chem. Res. (M). 03, 83

(1994).

122. Heterobimetallic chelates with 2–amino–3–formyl chromone. F. Arjmand, S.

Tabassum, S. A. A. Zaidi and K. S. Siddiqi, Main Group Met. Chem. 17, 429

(1994).

123. Complexes of lanthanide(III) ions with a Schiff base derived from S–benzoyl p–

aminobenzene sulphonamide dithiocarbamate and salicyaldehyde. S. Tabassum, F.

Arjmand, K. S. Siddiqi, S. A. A. Zaidi and F. Caruso, Synth.React. Inorg. Met.

Org. Chem. 23, 1425 (1993).

124. Lanthanide complexes of 2,2’–Bis–(1H,3H,5H)–pyrimidine–4,6–Dione–[1,3]–

diiminopropane and 2,2’–Bis–5,5, Diethyl Pyrimidin (1H,3H)–pyrimidine–4,6–

dione[1,3]–Diiminopropane.K. S. Siddiqi, A. Bashar, S. Tabassum, F. Arjmand

and S. A. A. Zaidi, Synth. React. Inorg. Met. Org. Chem. 23, 1617 (1993).

PAPERS IN NATIONAL AND INTERNATIONAL CONFERENCES

1. Paper presented in National Conference on “emerging trends in Chemical

sciences’ organized by Department of Chemistry, Aligarh Muslim University,

Aligarh, 24–25th Feb (2018)

2. Paper presented (oral presentation) in 1st International Conference on

Nanotechnology and Biomaterials: New Trends in Bone Tissue Engineering

held at Ras Sudr, South Sinai, Egypt.

3. Paper presented (oral presentation) in 21st International Conference of Indian

Society of Chemists and Biologists (ISCB) held at Central Drug Research

Institute, Lucknow.

4. Paper presented (oral presentation) in 23st International Conference of Indian

Society of Chemists and Biologists (ISCB) held at SRM University Chennai.

16

5. Paper presented (oral presentation) in “11th International Conference on

Chemistry and its Role in Development” held at Mansoura, Sharm–El–Sheikh,

Egypt, 11–15th Mar (2013)

6. Paper presented in “International Conference on Chemistry: Frontiers and

Challenges” held at Aligarh Muslim University, Aligarh, 2–3rd Mar (2013)

7. Paper presented at 31st national Conference of the Indian Council of Chemists

held at Saurashtra University, Rajkot, 26–28th Dec (2012)

8. Paper presented in National Conference on New Vistas in Chemistry held at

Aligarh Muslim University, Aligarh, 2–3rd Mar (2012)

9. Paper contributed to 48th Annual Convention of Chemists, held on 3–7th Dec,

2011, Allahabad University, Allahabad. (2011)

10. Paper contributed to national conference, CRSI 2011 held on 4–6th February

2011, KIIT University, Bhubaneswar, India

11. Paper contributed to International conference, canBIC 2011 held on 31st–may–

4th june 2011, Canada. (2011).

12. Paper contributed to International conference, Eu–1 Inorg. chem conference,

RSC held in Manchester, UK on 11th–14th April (2011)

13. Paper presented in ISCB International conference held at Saurashtra University,

Rajkot 3rd–7th Feb (2011.)

14. Paper presented in International conference held at Aligarh Muslim University,

Aligarh, 5–6th March, (2011.)

15. Paper presented in National conference of ICC held at Panjab University,

Chandigarh, 19th –21st Dec, (2010).

16. Paper presented in National symposium on Recent Trends in Chemical Science

held at Aligarh Muslim University, Aligarh, 24 & 25 Feb, (2010).

17. Paper presented in 12th National symposium of Chemical Research Society of

India (CRSI) held at Indian Institute of Chemical Technology, Hyderabad, 5–

7th Feb, (2010).

18. Paper presented in International Symposium on Cancer Chemoprevention and

Translational Research, School of Life Sciences, JNU, New Delhi, Dec

21, (2009).

19. Paper presented in 13th ISCB International conference on Interplay of Chemical

and Biological Sciences: Impact on Health and Environment held at University

of Delhi, Delhi, 26th Feb–1st March, (2009).

20. Paper presented at the Gordon Research Conference on Inorganic Chemistry

held at Salve Regina University in New Port, RI United States, 13th –18th July,

(2008).

21. Paper presented in National symposium on Emerging trends in Advanced

Chemistry–08 (ETAC–08) held at Centre of Advanced Studies, Deptt. Of

17

Chemistry, University of Rajasthan, Rajasthan, 8–10th March, (2008).

22. Paper presented in 10th National symposium of Chemical Research Society of

India (CRSI) held at Indian Institute of Sciences, Bangalore, 1–3rd Feb, (2008).

23. Paper presented in 9th National symposium of Chemical Research Society of

India (CRSI) held at University of Delhi, Delhi, 1th– 4th Feb, (2007).

24. Paper presented at 25thConference of the Indian Council of Chemists held at

Birla College, Kalyan, Mumbai, 27th – 29th December (2006).

25. Paper presented in Joint International conference on Building Bridges, Forging

Bonds for 21st Century Organic Chemistry and Chemical Biology (OCCB)

organized by American Chemical Society– Council of Scientific & Industrial

Research (ACS–CSIR) held at Pune, 7–9 January (2006).

26. Paper presented in 11th Symposium on Modern Trends in Inorganic Chemistry

(MTIC–XI) held at Indian Institute of Technology, Delhi, 8–10 December

(2005).

27. Paper presented at 7th National symposium in Chemistry held at Indian

Association for the Cultivation of Science, Kolkata, 4th–6th Feb. (2005).

28. Paper presented at 23ndConference of the Indian Council of Chemists held at K.

C. College, Church Gate, Mumbai, 29th – 31th October (2004).

29. Paper presented at 7th National Conference of Indian Society of Chemists and

Biologists held at Dr. B. R. Ambedkar University, Agra 26th –28th December

(2003).

30. Paper presented at 22ndConference of the Indian Council of Chemists held at

I.I.T.,Roorkee 17th – 19th October (2003).

31. Paper contributed to International symposium on drug discovery, and process

Research (DDPR–2003), held at Shivaji University, Kolhapur, 25–27th January

(2003).

32. Paper presented at 21st Conference of the Indian Council of Chemists held at R.

D. University, Jabalpur, 23–26th October (2002).

33. Paper contributed to 20th Conference of the Indian Council of Chemists held at

Mysore University, Mysore, 22–24th December (2001).

34. Paper presented at International Conference on Advances in Bioinorganic

Chemistry held at TIFR, Bombay, 20–24th November. (2000).

35. Paper contributed to symposium on Advances in Bioinorganic Chemistry held

at TIFR Bombay, 7–11th October (1996).

36. Paper contributed to Indian Council of Chemists held at Aurangabad, 24–26th

October (1996).

37. Paper presented at National Conference on Recent Trends in Vibrational

spectroscopy held at Merrut, 26–28th February. (1996).

38. Paper presented at Indian Council of Chemists at Institute of Science, Bombay,

28–30th December. (1995).

18

39. Paper presented at symposium on current trends in coordination chemistry at

CUSAT, Cochin, 23–25th March. (1995).

40. Paper contributed to National Academy of Science held at Udaipur. 9–11th

February (1993).

41. Paper contributed to 29th Annual Convention of Chemists, Reva (1992).

42. Paper contributed to European Research Conference held at Sheffield, U.K.

July, (1992).

43. Paper contributed to ICC held at Goa (1991).

44. Paper presented at National Academy of Science held at Allahabad 3–5th May.

(1990).

45. Paper contributed to Sixth IUPAC Conferences on Organometallic Chem.

directed towards organic synthesis held at Utrecht Netherlands. 25–29th August

(1991).

46. Paper contributed to XIV International Conference on Coordination Chemistry

held at Detroit, Michigan U.S.A. 19–24th August (1990).

19

Annexure–1

Ph.D thesis guided

1) Synthesis, Characterization and Biocidal Activity of Novel Metal Chelates with

Asymmetric Organic Ligands.2001 (Fareeda Athar).

2) Physico–Chemical and Biological Studies on Novel Metal Complexes of Oxygen,

Nitrogen and Sulphur Containing Ligands.2004 (Bhawana Mohani).

3) Synthesis and Biological Activity of New Dinuclear Complexes of Nitrogen and

Oxygen Containing Ligands.2005 (Shamima Parveen).

4) Synthesis of New Asymmetric Metal Complexes and Their Interaction with DNA

bases.2006 (Mala Chauhan).

5) Synthesis of Metallated Macrocycle and Their Interaction with DNA/Nucleotides.

2008 (Mubashira Aziz).

6) Synthesis, Characterization and Biological Studies of New Metal Complexes.2010

(Mohd. Muddassir)

7) Binding studies of achiral and chiral metal complexes with CT DNA and nucleotides.

2011 (Fatima Sayeed)

8) Synthesis and characterization of new asymmetric metal based potential

Chemotherapeutic agents and their in vitro DNA binding studies. 2013 (Jamsheera A)

9) Physico‒chemical and biological studies of new asymmetric metal complexes.

2013(Shazia Parveen).

10) Interaction studies of metal-based potential cancer chemotherapeutic agents with

biomolecules. 2014 (Manal Shamsi Mohammed).

11) Synthesis, characterization and biological studies of new potential metal‒based

drugs.2014 (Rahman Alizadeh)

12) Synthesis, characterization and in vitro DNA binding studies on new metal based

potential antitumor agents. 2015 ( Imtiyaz Yousuf)

13) Design and synthesis of new chiral metal complexes: Stereospecific interaction of

enantiomers with DNA/RNA. 2017 (Sabiha Parveen)

14) Synthesis, characterization of new metal-based antitumor chemotherapeutic

complexes and their biological evaluation. 2017 (Surbhi Sharma)

20

On going Ph.Ds 4 -Siffen Zehra

-Zeenat Afsan

-Huzaifa Yasir Khan

-Salman Khursheed

M.Phil dissertations guided

1) Interaction Studies of Transition Metals Complexes with Human Serum Albumin

(HSA)– 2007 (Poonam Tewatia).

2) Synthesis and Characterization of Biological Significant Chiral Compounds–

2008 (Bushra Jamil).

3) Synthesis, characterization and comparative in vitro DNA binding studies of

transition metal complexes { Fe(II), Co(II), Ni(II), Cu(II) & Zn(II)}−2016

(Siffeen Zehra)

4) Metal-Nucleic Acid interaction studies of some mixed ligand bioactive

complexes−2016 (Sarah Saif)